Novo Holdings A/S Q3 2018 Filing
Filed November 14, 2018
Portfolio Value
$1.3T
Holdings
22
Report Date
Q3 2018
Filing Type
13F-HR
All Holdings (22 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | INGNINOGEN INC | 3,549,320 | $866.5B | 68.99% | |
| 2 | GKOSGLAUKOS CORP | 602,709 | $39.1B | 3.11% | |
| 3 | CRVSCORVUS PHARMACEUTICALS INC | 4,420,516 | $37.9B | 3.02% | |
| 4 | XLRNACCELERON PHARMA INC | 650,000 | $37.2B | 2.96% | |
| 5 | AKBAAKEBIA THERAPEUTICS INC | 3,100,000 | $27.4B | 2.18% | |
| 6 | AERIEURAERIE PHARMACEUTICALS INC | 408,562 | $25.1B | 2.00% | |
| 7 | —DERMIRA INC | 1,993,746 | $24.5B | 1.95% | |
| 8 | KIDSORTHOPEDIATRICS CORP | 654,549 | $24.0B | 1.91% | |
| 9 | —ENTASIS THERAPEUTICS HLDGS I | 2,181,843 | $23.7B | 1.89% | |
| 10 | MRUSMERUS N V | 1,102,795 | $21.8B | 1.73% | |
| 11 | AM6AMICUS THERAPEUTICS INC | 1,647,870 | $19.9B | 1.59% | |
| 12 | STIMNEURONETICS INC | 525,000 | $16.8B | 1.34% | |
| 13 | SPNEUSDSEASPINE HLDGS CORP | 983,037 | $15.3B | 1.22% | |
| 14 | —MENLO THERAPEUTICS INC | 1,436,313 | $14.1B | 1.13% | |
| 15 | —NABRIVA THERAPEUTICS PLC | 4,703,720 | $12.7B | 1.01% | |
| 16 | GLPGGALAPAGOS NV | 87,481 | $9.8B | 0.78% | |
| 17 | VRNAVERONA PHARMA PLC | 740,740 | $9.3B | 0.74% | |
| 18 | —INVUITY INC | 1,209,854 | $9.0B | 0.71% | |
| 19 | —UNUM THERAPEUTICS INC | 665,181 | $6.9B | 0.55% | |
| 20 | —WRIGHT MED GROUP N V | 4,622,032 | $6.5B | 0.52% | |
| 21 | CRNXCRINETICS PHARMACEUTICALS IN | 150,000 | $4.3B | 0.34% | |
| 22 | —RA PHARMACEUTICALS INC | 225,000 | $4.1B | 0.32% |